Skip to search.
 BSE Up0.15% NSE Up0.28%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM

27.61 Down 0.34(1.22%) 10:47PM - Nasdaq Real Time Price

Add to Portfolio
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Avg. Estimate0.070.100.480.94
No. of Analysts4.004.005.005.00
Low Estimate0.040.090.360.74
High Estimate0.130.110.631.28
Year Ago EPS-0.11-0.010.060.48
Revenue EstCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Avg. Estimate9.59M10.79M45.59M61.69M
No. of Analysts5555
Low Estimate8.90M9.50M43.00M55.90M
High Estimate11.50M11.78M47.90M65.50M
Year Ago Sales5.74M6.38M31.39M45.59M
Sales Growth (year/est)67.00%69.30%45.20%35.30%
Earnings HistoryJun 2012Sep 2012Dec 2012Mar 2013
EPS Est-0.02-0.040.210.09
EPS Actual-0.11-0.010.190.16
Difference-0.090.03-0.020.07
Surprise %-450.00%75.00%-9.50%77.80%
EPS TrendsCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Current Estimate0.070.100.480.94
7 Days Ago0.070.100.480.94
30 Days Ago0.040.100.460.91
60 Days Ago0.040.100.460.85
90 Days Ago0.030.100.380.81
EPS RevisionsCurrent Qtr.
Jun 2013		Next Qtr.
Sep 2013		Current Year
Dec 2013		Next Year
Dec 2014
Up Last 7 Days2200
Up Last 30 Days3311
Down Last 30 Days0011
Down Last 90 DaysN/AN/AN/AN/A
Growth EstLGNDIndustrySectorS&P 500
Current Qtr.163.60%N/AN/A11.80%
Next Qtr.1,100.00%259.80%N/A16.60%
This Year700.00%23.60%9.70%9.10%
Next Year95.80%64.60%13.20%12.60%
Past 5 Years (per annum)-65.30%N/AN/AN/A
Next 5 Years (per annum)17.00%13.48%13.69%9.37%
Price/Earnings (avg. for comparison categories)58.353.873.1113.33
PEG Ratio (avg. for comparison categories)3.432.20-0.701.33
Currency in USD.